Brighton Jones LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4M Buy
+15,617
New +$15.8M 0.32% 44
2025
Q4
Sell
-11,909
Closed -$9.09M 557
2025
Q3
$9.09M Buy
11,909
+1,021
+9% +$760K 0.22% 56
2025
Q2
$8.49M Buy
10,888
+467
+4% +$363K 0.23% 58
2025
Q1
$8.61M Buy
10,421
+824
+9% +$686K 0.28% 52
2024
Q4
$7.41M Buy
9,597
+1,730
+22% +$1.43M 0.21% 60
2024
Q3
$6.97M Sell
7,867
-3,630
-32% -$3.26M 0.26% 53
2024
Q2
$10.4M Buy
11,497
+49
+0.4% +$39.2K 0.34% 45
2024
Q1
$8.91M Buy
11,448
+1,774
+18% +$1.26M 0.32% 44
2023
Q4
$5.64M Buy
9,674
+577
+6% +$337K 0.24% 62
2023
Q3
$4.89M Buy
9,097
+576
+7% +$297K 0.25% 62
2023
Q2
$4M Sell
8,521
-55
-0.6% -$23.1K 0.2% 70
2023
Q1
$2.95M Buy
8,576
+2,330
+37% +$786K 0.17% 78
2022
Q4
$2.29M Sell
6,246
-186
-3% -$65.9K 0.14% 91
2022
Q3
$2.08M Buy
6,432
+100
+2% +$31.7K 0.12% 95
2022
Q2
$2.05M Buy
6,332
+63
+1% +$18.9K 0.12% 98
2022
Q1
$1.79M Buy
6,269
+89
+1% +$22.9K 0.08% 115
2021
Q4
$1.71M Buy
6,180
+176
+3% +$44.6K 0.08% 116
2021
Q3
$1.39M Buy
6,004
+312
+5% +$77K 0.07% 126
2021
Q2
$1.31M Sell
5,692
-498
-8% -$100K 0.07% 125
2021
Q1
$1.16M Buy
6,190
+227
+4% +$44.4K 0.07% 132
2020
Q4
$1.01M Buy
5,963
+303
+5% +$45.2K 0.06% 131
2020
Q3
$838K Buy
5,660
+19
+0.3% +$2.94K 0.06% 133
2020
Q2
$926K Sell
5,641
-21
-0.4% -$3.22K 0.08% 112
2020
Q1
$785K Sell
5,662
-1,300
-19% -$179K 0.08% 115
2019
Q4
$915K Buy
6,962
+116
+2% +$13.4K 0.1% 124
2019
Q3
$766K Buy
6,846
+202
+3% +$22.5K 0.09% 122
2019
Q2
$736K Sell
6,644
-29
-0.4% -$3.42K 0.09% 125
2019
Q1
$866K Buy
6,673
+1,343
+25% +$163K 0.1% 114
2018
Q4
$617K Buy
5,330
+139
+3% +$15.5K 0.09% 118
2018
Q3
$557K Sell
5,191
-20
-0.4% -$2K 0.07% 146
2018
Q2
$445K Sell
5,211
-990
-16% -$81.3K 0.06% 184
2018
Q1
$480K Sell
6,201
-1,021
-14% -$82.2K 0.07% 160
2017
Q4
$610K Buy
7,222
+122
+2% +$10.4K 0.07% 133
2017
Q3
$607K Sell
7,100
-528
-7% -$43.3K 0.08% 131
2017
Q2
$628K Sell
7,628
-610
-7% -$49.8K 0.09% 118
2017
Q1
$693K Buy
+8,238
New +$660K 0.17% 47
2016
Q4
Sell
-8,303
Closed -$666K 161
2016
Q3
$666K Buy
8,303
+76
+0.9% +$6.08K 0.11% 101
2016
Q2
$648K Buy
8,227
+852
+12% +$64.1K 0.11% 99
2016
Q1
$531K Buy
7,375
+1,282
+21% +$97K 0.1% 106
2015
Q4
$513K Buy
6,093
+107
+2% +$8.88K 0.1% 105
2015
Q3
$501K Buy
5,986
+2,528
+73% +$213K 0.11% 101
2015
Q2
$289K Sell
3,458
-933
-21% -$71.1K 0.07% 141
2015
Q1
$319K Sell
4,391
-699
-14% -$49.8K 0.07% 134
2014
Q4
$351K Sell
5,090
-247
-5% -$16.7K 0.08% 132
2014
Q3
$346K Buy
5,337
+380
+8% +$24.1K 0.08% 134
2014
Q2
$308K Sell
4,957
-178
-3% -$10.6K 0.07% 134
2014
Q1
$302K Buy
5,135
+180
+4% +$10K 0.07% 132
2013
Q4
$253K Sell
4,955
-1,627
-25% -$81.5K 0.06% 154
2013
Q3
$331K Buy
+6,582
New +$345K 0.09% 103

Other funds holding LLY

Brighton Jones LLC's LLY Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Eli Lilly (LLY) in Q1 2026: 15,617 shares worth $14.4M. The stake represents 0.32% of the portfolio and ranks #44 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in LLY as recently as Q3 2025.

Brighton Jones LLC first reported a position in LLY in Q3 2013 and has held it in 49 quarters since. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Brighton Jones LLC held 15,617 shares of Eli Lilly worth $14.4M as of Q1 2026.
  • Eli Lilly was a new Brighton Jones LLC position in Q1 2026.
  • Eli Lilly made up 0.32% of Brighton Jones LLC's portfolio in Q1 2026, its #44 holding.
  • Brighton Jones LLC first reported a position in Eli Lilly in Q3 2013 and has held it in 49 quarters since.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.